About Dane Andreeff
Form D filings for HDL Therapeutics from 2019 to 2023 list Dane Andreeff as director.
Dane Andreeff first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Dane Andreeff in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Dane Andreeff works with at each company, as listed on that company's latest Form D.
HDL Therapeutics, Inc. · Form D, Jul 10, 2023